Case Report
BibTex RIS Cite

Amlodipine-induced gingival hyperplasia

Year 2024, , 99 - 102, 29.10.2024
https://doi.org/10.56016/dahudermj.1442236

Abstract

Calcium channel blockers (CCB) are the best-known, most widely used drugs in the treatment of hypertension in the world. Gingival hyperplasia is one of the uncommon side effects of CCB usage. Among CCBs, it’s most commonly seen due to nifedipine. Gingival hyperplasia is rarely seen with the use of amlodipine. The mechanism of drug-induced gingival enlargement is not entirely understood, but it’s clear that it is due to multifactorial influences. Although the pharmacologic effect of each drug is different, all of them are estimated to act similarly to the secondary target tissue, i.e., the gingival connective tissue, thus resulting in common histopathological findings. Both inflammatory and non-inflammatory mechanisms are involved. This case has been presented to emphasize that the development of gingival hyperplasia in patients with hypertension could be a side effect of amlodipine usage.

Ethical Statement

Ethics committee approval is not necessary in the case reports.

Thanks

There are so many article that are so beneficial our practice. Thanks and hope to become one of them.

References

  • Cekmez F, Pirgon O, Tanju IA. Idiopathic gingival hyperplasia. Int J Biomed Sci. 2009 Jun;5(2):198-200.
  • Eggerath J, English H, Leichter JW. Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment. J N Z Soc Periodontol. 2005;(88):7-14.
  • Haria M, Wagstaff AJ. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs. 1995 Sep;50(3):560-86. doi: 10.2165/00003495-199550030-00009. Erratum in: Drugs 1995 Nov;50(5):896.
  • Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol. 1999 Jan;70(1):63-7. doi: 10.1902/jop.1999.70.1.63.
  • Sucu M, Yuce M, Davutoglu V. Amlodipine-induced massive gingival hypertrophy. Can Fam Physician. 2011 Apr;57(4):436-7.
  • Prisant LM, Herman W. Calcium channel blocker induced gingival overgrowth. J Clin Hypertens (Greenwich). 2002 Jul-Aug;4(4):310-1. doi: 10.1111/j.1524-6175.2002.01095.x.
  • Tejnani A, Mani A, Sodhi NK, Mehta A, Gourkhede S, Thorat V, Marawar P. Incidence of amlodipine-induced gingival overgrowth in the rural population of Loni. J Indian Soc Periodontol. 2014 Mar;18(2):226-8. doi: 10.4103/0972-124X.131332.
  • Ellis JS, Seymour RA, Thomason JM, Monkman SC, Idle JR. Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. Lancet. 1993 Apr 24;341(8852):1102-3. doi: 10.1016/0140-6736(93)92470-e.
  • Bajkovec L, Mrzljak A, Likic R, Alajbeg I. Drug-induced gingival overgrowth in cardiovascular patients. World J Cardiol. 2021 Apr 26;13(4):68-75. doi: 10.4330/wjc.v13.i4.68.
  • Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis. Oral Dis. 2015 Jan;21(1):e51-61. doi: 10.1111/odi.12264. Epub 2014 Aug 7.
Year 2024, , 99 - 102, 29.10.2024
https://doi.org/10.56016/dahudermj.1442236

Abstract

References

  • Cekmez F, Pirgon O, Tanju IA. Idiopathic gingival hyperplasia. Int J Biomed Sci. 2009 Jun;5(2):198-200.
  • Eggerath J, English H, Leichter JW. Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment. J N Z Soc Periodontol. 2005;(88):7-14.
  • Haria M, Wagstaff AJ. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. Drugs. 1995 Sep;50(3):560-86. doi: 10.2165/00003495-199550030-00009. Erratum in: Drugs 1995 Nov;50(5):896.
  • Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol. 1999 Jan;70(1):63-7. doi: 10.1902/jop.1999.70.1.63.
  • Sucu M, Yuce M, Davutoglu V. Amlodipine-induced massive gingival hypertrophy. Can Fam Physician. 2011 Apr;57(4):436-7.
  • Prisant LM, Herman W. Calcium channel blocker induced gingival overgrowth. J Clin Hypertens (Greenwich). 2002 Jul-Aug;4(4):310-1. doi: 10.1111/j.1524-6175.2002.01095.x.
  • Tejnani A, Mani A, Sodhi NK, Mehta A, Gourkhede S, Thorat V, Marawar P. Incidence of amlodipine-induced gingival overgrowth in the rural population of Loni. J Indian Soc Periodontol. 2014 Mar;18(2):226-8. doi: 10.4103/0972-124X.131332.
  • Ellis JS, Seymour RA, Thomason JM, Monkman SC, Idle JR. Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. Lancet. 1993 Apr 24;341(8852):1102-3. doi: 10.1016/0140-6736(93)92470-e.
  • Bajkovec L, Mrzljak A, Likic R, Alajbeg I. Drug-induced gingival overgrowth in cardiovascular patients. World J Cardiol. 2021 Apr 26;13(4):68-75. doi: 10.4330/wjc.v13.i4.68.
  • Brown RS, Arany PR. Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis. Oral Dis. 2015 Jan;21(1):e51-61. doi: 10.1111/odi.12264. Epub 2014 Aug 7.
There are 10 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Case Reports
Authors

Gulbın Cetınkaya 0000-0002-1354-4555

Publication Date October 29, 2024
Submission Date March 5, 2024
Acceptance Date May 8, 2024
Published in Issue Year 2024

Cite

EndNote Cetınkaya G (October 1, 2024) Amlodipine-induced gingival hyperplasia. DAHUDER Medical Journal 4 4 99–102.



DAHUDER Medical Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png